<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29</volume><submitter>Liu J</submitter><pubmed_abstract>BACKGROUND Ginkgetin inhibits growth of tumor cells, reducing blood lipids, and improving atherosclerosis, but the protective effect of ginkgetin in donation after cardiac death (DCD) livers is still unknown. The aim of this study was to determine whether pretreatment of DCD donor livers with ginkgetin can reduce inflammatory response through the JAK2/STAT3 signaling pathway. MATERIAL AND METHODS Twenty male Sprague-Dawley rats (200-250 g) were randomly divided into 4 groups: Sham, DCD, Ginkgetin (0.6 mg/kg) pretreatment 1 h before surgery, and Ginkgetin (0.6 mg/kg) plus broussonin E (0.3 mg/kg) (JAK2/STAT3 signaling agonist) pretreatment 1 h before surgery. Rat livers were subjected to 30 min warm ischemia and 24 h cold storage to simulate the preservation process of DCD donor livers, fol</pubmed_abstract><journal>Annals of transplantation</journal><pagination>e944153</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11299463</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway.</pubmed_title><pmcid>PMC11299463</pmcid><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Xiao J</pubmed_authors><pubmed_authors>Deng Q</pubmed_authors><pubmed_authors>Fu Z</pubmed_authors><pubmed_authors>Xiao Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ginkgetin Pretreatment Reduces Inflammatory Response in DCD Donor Liver via JAK2/STAT3 Signaling Pathway.</name><description>BACKGROUND Ginkgetin inhibits growth of tumor cells, reducing blood lipids, and improving atherosclerosis, but the protective effect of ginkgetin in donation after cardiac death (DCD) livers is still unknown. The aim of this study was to determine whether pretreatment of DCD donor livers with ginkgetin can reduce inflammatory response through the JAK2/STAT3 signaling pathway. MATERIAL AND METHODS Twenty male Sprague-Dawley rats (200-250 g) were randomly divided into 4 groups: Sham, DCD, Ginkgetin (0.6 mg/kg) pretreatment 1 h before surgery, and Ginkgetin (0.6 mg/kg) plus broussonin E (0.3 mg/kg) (JAK2/STAT3 signaling agonist) pretreatment 1 h before surgery. Rat livers were subjected to 30 min warm ischemia and 24 h cold storage to simulate the preservation process of DCD donor livers, fol</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-26T05:30:25.515Z</modification><creation>2025-04-06T11:30:46.398Z</creation></dates><accession>S-EPMC11299463</accession><cross_references><pubmed>39016049</pubmed><doi>10.12659/AOT.944153</doi></cross_references></HashMap>